(NASDAQ:MLTX), NEW YORK, Nov. 10, 2025 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of MoonLake Immunotherapeutics (NASDAQ: MLTX) between March 10, 2024 and September 29, 2025, both dates inclusive (the “Class Period”), of the important December 15, 2025 lead plaintiff deadline. SO WHAT: If […]

ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages MoonLake Immunotherapeutics Investors to Secure Counsel Before Important Deadline in Securities Class Action – MLTX GlobeNewswire November 10, 2025 NEW YORK, Nov. 10, 2025 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of MoonLake Immunotherapeutics (NASDAQ: MLTX)

Edelson Lechtzin LLPis investigating potential violations of the federal securities laws involving Arcturus Therapeutics Holdings Inc. (“Arcturus”) (NASDAQ: ARCT), resulting from allegations of providing potentially misleading business information to the investing public. https://mma.prnewswire.com/media/2457789/logo2_Logo.jpg If you have non-public information that could assist in the Arcturus Investigation or if you are an Arcturus investor who suffered a

Deadline Alert: aTyr Pharma Inc. (ATYR) Shareholders Who Lost Money Urged To Contact Glancy Prongay & Murray LLP About Securities Fraud Lawsuit GlobeNewswire November 10, 2025 LOS ANGELES, Nov. 10, 2025 (GLOBE NEWSWIRE) — Glancy Prongay & Murray LLP reminds investors of the upcoming December 8, 2025 deadline to file a lead plaintiff motion in

AgVault is launching its novel precision fermentation technology to produce a yeast product which surpasses existing standard yeast options on a whole-cell basis across multiple categories, including: https://mma.prnewswire.com/media/2744601/AgVault_Logo.jpg — Up to 200% the prebiotic content — Higher immune-modulating Beta Glucans — 50% protein — Higher percentage of essential amino acids — Increased complex carbohydrate content

NEW YORK, NY / ACCESS Newswire / November 10, 2025 / – SueWallSt: Class Action Filed Against aTyr Pharma, Inc. – Contact Levi & Korsinsky A Class Action lawsuit was filed on behalf of investors who lost money as a result of alleged securities fraud between November 7, 2024 and September 12, 2025. If you

NEW YORK, NY / ACCESS Newswire / November 10, 2025 / – SueWallSt: Class Action Filed Against MoonLake Immunotherapeutics – Contact Levi & Korsinsky A Class Action lawsuit was filed on behalf of investors who lost money as a result of alleged securities fraud between March 10, 2024 and September 29, 2025. If you suffered

NEW YORK, NY / ACCESS Newswire / November 10, 2025 / Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into Stride, Inc. (NYSE:LRN) for potential violations of the federal securities laws. If you invested in Stride, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases/stride-inc-class-action-lawsuit. Why Is Stride Being Investigated

(NYSE:BAX), LOS ANGELES, Nov. 10, 2025 (GLOBE NEWSWIRE) — Glancy Prongay & Murray LLP reminds investors of the upcoming December 15, 2025 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Baxter International, Inc. (“Baxter” or the “Company”) (NYSE: BAX) common stock between

Deadline Alert: Baxter International, Inc. (BAX) Shareholders Who Lost Money Urged To Contact Glancy Prongay & Murray LLP About Securities Fraud Lawsuit GlobeNewswire November 10, 2025 LOS ANGELES, Nov. 10, 2025 (GLOBE NEWSWIRE) — Glancy Prongay & Murray LLP reminds investors of the upcoming December 15, 2025 deadline to file a lead plaintiff motion in